ES2180958T3 - Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro. - Google Patents

Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro.

Info

Publication number
ES2180958T3
ES2180958T3 ES97914258T ES97914258T ES2180958T3 ES 2180958 T3 ES2180958 T3 ES 2180958T3 ES 97914258 T ES97914258 T ES 97914258T ES 97914258 T ES97914258 T ES 97914258T ES 2180958 T3 ES2180958 T3 ES 2180958T3
Authority
ES
Spain
Prior art keywords
erythropoyetin
iron
preparations
combined pharmaceutical
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97914258T
Other languages
English (en)
Inventor
Paul Lehmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2180958T3 publication Critical patent/ES2180958T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Clamps And Clips (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a una preparación farmacéutica combinada que comprende 250-20.000 U de una preparación de EPO en una forma individual de administración y 5-20 mg de un complejo de Fe(III). Dichas preparación de EPO y dicho complejo de Fe(III) pueden estar disponibles en una forma de administración separada u homogénea. Dicha preparación farmacéutica se utiliza para tratar pacientes anémicos o hemodializados.
ES97914258T 1997-03-18 1997-03-18 Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro. Expired - Lifetime ES2180958T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1997/001343 WO1998041226A1 (de) 1997-03-18 1997-03-18 Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate

Publications (1)

Publication Number Publication Date
ES2180958T3 true ES2180958T3 (es) 2003-02-16

Family

ID=8166555

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97914258T Expired - Lifetime ES2180958T3 (es) 1997-03-18 1997-03-18 Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro.

Country Status (19)

Country Link
US (1) US6710028B2 (es)
EP (1) EP0977582B1 (es)
JP (1) JP2000514092A (es)
AT (1) ATE222118T1 (es)
AU (1) AU726801B2 (es)
BR (1) BR9714632A (es)
CA (1) CA2284910C (es)
CZ (1) CZ296960B6 (es)
DE (1) DE59707988D1 (es)
DK (1) DK0977582T3 (es)
ES (1) ES2180958T3 (es)
HU (1) HU226204B1 (es)
IL (2) IL131959A0 (es)
NO (1) NO324661B1 (es)
NZ (1) NZ337465A (es)
PL (1) PL187479B1 (es)
PT (1) PT977582E (es)
SI (1) SI0977582T1 (es)
WO (1) WO1998041226A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US20040198663A1 (en) * 2003-04-04 2004-10-07 Baker John E. Method of treating cardiac ischemia by using erythropoietin
AU2003291796A1 (en) * 2003-06-27 2005-01-13 Igor A. Pomytkin Synergistic compositions comprising erythropoietin and succinic acid (salt)
DK1696947T3 (en) * 2003-12-19 2014-03-17 Hoffmann La Roche APPLICATION OF ERYTHROPOIETIN IN THE TREATMENT OF DISORDERS OF THE IRON DISTRIBUTION IN CHRONIC INFLAMMATORY INTESTINAL DISEASES
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
ES2962777T3 (es) 2007-11-15 2024-03-21 Amgen Inc Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
EP2067752A1 (en) * 2007-12-06 2009-06-10 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Construction material
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
ES2667066T3 (es) 2010-05-24 2018-05-09 The Trustees Of Columbia University In The City Of New York Proteínas NGAL mutantes y usos de las mismas
WO2014081980A2 (en) 2012-11-21 2014-05-30 The Trustees Of Columbia University In The City Of New York Mutant ngal proteins and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
KR880012235A (ko) * 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
US20020065214A1 (en) * 2000-11-29 2002-05-30 Adrian Iaina Method of treating congestive heart failure
MXPA03005406A (es) * 2000-12-20 2003-09-25 Hoffmann La Roche Conjugados de eritropoyetina.

Also Published As

Publication number Publication date
CA2284910A1 (en) 1998-09-24
NO994511L (no) 1999-09-17
US6710028B2 (en) 2004-03-23
EP0977582B1 (de) 2002-08-14
PL187479B1 (pl) 2004-07-30
WO1998041226A9 (de) 1999-11-25
CA2284910C (en) 2003-01-28
HUP0001409A3 (en) 2003-08-28
BR9714632A (pt) 2000-05-23
DK0977582T3 (da) 2002-12-16
ATE222118T1 (de) 2002-08-15
CZ9903300A3 (cs) 2001-03-14
US20020094948A1 (en) 2002-07-18
JP2000514092A (ja) 2000-10-24
IL131959A0 (en) 2001-03-19
HU226204B1 (en) 2008-06-30
EP0977582A1 (de) 2000-02-09
PT977582E (pt) 2002-12-31
AU726801B2 (en) 2000-11-23
IL131959A (en) 2006-12-31
CZ296960B6 (cs) 2006-08-16
PL335858A1 (en) 2000-05-22
HUP0001409A2 (en) 2001-03-28
SI0977582T1 (en) 2002-12-31
NZ337465A (en) 2002-04-26
AU2157297A (en) 1998-10-12
DE59707988D1 (de) 2002-09-19
NO994511D0 (no) 1999-09-17
NO324661B1 (no) 2007-11-26
WO1998041226A1 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
ES2180958T3 (es) Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro.
BG103552A (bg) Терапевтични средства
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
EP0903143A3 (en) Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels
DE122006000015I1 (de) Asp-B28-Insulinkristalle
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE59800863D1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
PT1007055E (pt) Utilizacao de amifostina
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.
MD980129A (en) Antiherpetic remedy
HU905694D0 (en) Medical preparations containing extracts of plantago major and calendula officinalis as active agents
UA36813A (uk) Збір для лікування серцевих неврозів, стресових станів, гіпертонічної хвороби, радіофобії (лон-5)
GEU1999444Y (en) Medicinal Means “Barambo”
IE871060L (en) Use of glycofurol in pharmaceutical preparations.